Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quipt Home Medical (QIPT) Depreciation & Amortization - Total (2023 - 2025)

Quipt Home Medical (QIPT) has disclosed Depreciation & Amortization - Total for 3 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization - Total rose 14.87% year-over-year to $10.9 million, compared with a TTM value of $40.8 million through Dec 2025, up 6.57%, and an annual FY2025 reading of $39.4 million, up 2.44% over the prior year.
  • Depreciation & Amortization - Total was $10.9 million for Q4 2025 at Quipt Home Medical, up from $10.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $10.9 million in Q4 2025 and bottomed at $9.3 million in Q1 2024.
  • Average Depreciation & Amortization - Total over 3 years is $9.9 million, with a median of $9.8 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization - Total dropped 1.75% in 2024, then rose 14.87% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $9.6 million in 2023, then dropped by 1.75% to $9.5 million in 2024, then increased by 14.87% to $10.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for QIPT at $10.9 million in Q4 2025, $10.4 million in Q3 2025, and $9.8 million in Q2 2025.